Actemra (Tocilizumab) Utilization Among Pregnant Women

    Basic Details
    Date Posted
    Monday, July 17, 2017
    Status
    Complete
    Medical Product
    Actemra
    tocilizumab
    Health Outcome(s)
    juvenile rheumatoid arthritis
    rheumatoid arthritis
    Description

    This report contains estimates of tocilizumab use that occurred during a pregnancy resulting in a liveborn delivery, or within 90 days prior to the estimated start of pregnancy. This query request was distributed to 16 Data Partners on February 9, 2017, and requested data that spanned from the time period of January 1, 2010 to September 30, 2015.

    Additional Details
    FDA Center
    CDER
    Time Period
    2010 - 2015
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All females 15 to 54 years of age with a live birth between January 2010 - December 2015